Abeona Therapeutics, Inc. (ABEO)
5.915
-0.12
(-2.07%)
USD |
NASDAQ |
Aug 28, 13:01
Abeona Therapeutics Cash from Operations (Quarterly) : -17.50M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.50M |
| March 31, 2026 | -19.80M |
| December 31, 2025 | -17.95M |
| September 30, 2025 | -21.19M |
| June 30, 2025 | -18.78M |
| March 31, 2025 | -18.40M |
| December 31, 2024 | -16.56M |
| September 30, 2024 | -12.23M |
| June 30, 2024 | -12.68M |
| March 31, 2024 | -14.54M |
| December 31, 2023 | -9.385M |
| September 30, 2023 | -5.746M |
| June 30, 2023 | -10.28M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -13.99M |
| September 30, 2022 | -6.791M |
| June 30, 2022 | -9.013M |
| March 31, 2022 | -13.69M |
| December 31, 2021 | -30.26M |
| September 30, 2021 | -10.33M |
| June 30, 2021 | -11.49M |
| March 31, 2021 | -13.58M |
| December 31, 2020 | -1.61M |
| September 30, 2020 | -10.70M |
| June 30, 2020 | -9.475M |
| Date | Value |
|---|---|
| March 31, 2020 | -13.23M |
| December 31, 2019 | -14.25M |
| September 30, 2019 | -18.25M |
| June 30, 2019 | -15.24M |
| March 31, 2019 | -15.08M |
| December 31, 2018 | |
| September 30, 2018 | -9.04M |
| June 30, 2018 | -9.022M |
| March 31, 2018 | -4.082M |
| December 31, 2017 | -5.326M |
| September 30, 2017 | -6.77M |
| June 30, 2017 | -4.982M |
| March 31, 2017 | -5.857M |
| December 31, 2016 | -3.393M |
| September 30, 2016 | -3.989M |
| June 30, 2016 | -3.116M |
| March 31, 2016 | -2.516M |
| December 31, 2015 | -2.877M |
| September 30, 2015 | -2.512M |
| June 30, 2015 | -1.871M |
| March 31, 2015 | -3.163M |
| December 31, 2014 | -1.102M |
| September 30, 2014 | -0.14M |
| June 30, 2014 | -0.244M |
| March 31, 2014 | -0.125M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 33.54M |
| Forum Markets, Inc. | -12.44M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 15.69M |
| Cash from Financing (Quarterly) | -3.335M |
| Free Cash Flow | -81.53M |
| Free Cash Flow Per Share (Quarterly) | -0.3151 |
| Free Cash Flow to Equity (Quarterly) | -14.67M |
| Free Cash Flow to Firm (Quarterly) | -17.28M |
| Free Cash Flow Yield | -24.73% |